Bionexus Gene Lab Corp. (BGLC)
Market Closed
16 Jun, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
2. 60
+0.1
+4%
After Hours
$
+0.05 +1.9231% 2. 65
4.3M Market Cap
- P/E Ratio
- Div Yield
15,977 Volume
- Eps
$ 2.5
Previous Close Want to track BGLC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Bionexus Gene Lab Corp. (BGLC) Statistics
Valuation metrics
Market Cap 4.3M
Enterprise value 556.33K
Trailing P/E (ttm) -1.78
Forward P/E -
PEG ratio 0.04
Price/Sales (ttm) 0.81
Price/Book (mrq) 0.64
Enterprise Value/Revenue 0.1
Enterprise Value/EBITDA -0.2
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 636.68K
Average volume (90 days) 92.7K
Price summary
52-Week low 1.07
52-Week high 15.6
Beta -
50-Day moving average 2.12
200-Day moving average 2.79
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 7 Apr 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.55%
Operating margin -0.55%
Operational effectiveness
Return on assets -0.14%
Return on equity -0.37%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 2.2
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.2
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.64
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 6.52%
Book value per share (mrq) 3.35
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
